Clinical Trial

Immunogenicity and Safety of Sequential 2vHPV-9vHPV Vaccination in Girls Aged 9-14 Years

Name: Immunogenicity and Safety of Sequential 2vHPV-9vHPV Vaccination in Girls Aged 9-14 Years — clinical trial record (NCT07281677)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

This study aims to assess the immunogenicity and safety of a sequential 2vhpv to 9vhpv immunization schedule in girls aged 9-14 years

Trial Details

NCT Number	NCT07281677
Lead Sponsor	Zhejiang Provincial Center for Disease Control and Prevention
Conditions	HPV Infection
Enrollment	400 participants
Start Date	2025-12-20
Primary Completion	2028-12-20 (estimated)
Study Completion	2029-11-13 (estimated)
Updated on ClinicalTrials.gov	2026-06-11